TAO Synergies Competitors and Similar CompaniesClear all

TAO Synergies's competitors and similar companies include Umoja Biopharma, AC Immune, Aprogen and Manifold Bio.

	TAO Synergies TAO Synergies (formerly known as Synaptogenix and Neurotrope Bioscience) is a company that engages in digital asset treasury strategy.	Umoja Biopharma Umoja Biopharma is a company engaged in immunotherapies discovery.	AC Immune AC Immune is a biopharmaceutical company developing therapeutics against Alzheimer´s disease and other conformational diseases.	Aprogen Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies.	Manifold Bio Manifold Bio is a biotechnology company.
Founding Date	Founding Date 2012	Founding Date 2019	Founding Date 2003	Founding Date 2000	Founding Date 2020
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Financial Services cryptocurrency fintech	Tags Healthcare biotech drug development pharma platform	Tags Healthcare biotech drug development pharma platform	Tags Healthcare biotech drug development pharma platform	Tags Healthcare biotech drug development pharma platform
Locations	Locations New York, US HQ Sarasota, US	Locations Seattle, US HQ Seattle, US	Locations Lausanne, CH HQ	Locations HQ	Locations Boston, US HQ
Employees	Employees 4	Employees 1951% increase	Employees 133	Employees 80	Employees 432% increase
Valuation ($)	Valuation ($) 4.3 m	Valuation ($) N/A	Valuation ($) 297.8 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $299.1k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) CHF3.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $38.3k (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $260.8k (FY, 2025)	Gross profit N/A	Gross profit CHF3.7m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($28.7m) (FY, 2025)	Net income N/A	Net income (CHF70.4m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 210m (about 5 years ago)	Latest funding round N/A	Latest funding round $ 16.7m (over 6 years ago)	Latest funding round $ 5.4m (almost 6 years ago)
Total funding raised	Total funding raised $ 21.9m	Total funding raised $ 263m	Total funding raised $ 117.4m	Total funding raised $ 16.7m	Total funding raised $ 5.4m